U.S. Markets close in 1 min.

Debby Goldsberry Named to Cannabis Business Executive 2017 Most Important Womens List Top 10

MESQUITE, NV / ACCESSWIRE / November 21, 2017 / Cannabis Sativa, Inc. (OTCQB: CBDS) is proud to announce that Debby Goldsberry, a member of the Cannabis Sativa Board of Directors, has been named in the Top 10 of Cannabis Business Executive's 2017 CBE 75 Most Important Women list:

https://www.cannabisbusinessexecutive.com/2017/11/2017-cbe-75-important-women

''Debby has been an important voice as an Independent Director and her experience and acumen is important to the future course of CBDS,'' said Cannabis Sativa CEO Mike Gravel.

Debby Goldsberry has nearly 30 years experience as a leader in the medical and adult use marijuana industry. She is executive director at Magnolia Wellness, an award-winning dispensary in Oakland, California, and is the managing director of the Berkeley Community Care Center dispensary at Amoeba Music. She co-founded the Berkeley Patients Group (BPG) medical cannabis collective in 1999, directing its growth for over 11 years. Goldsberry also owns and operates Emergent Management Consulting, a cannabusiness firm in Oakland. She developed and implemented standard operating procedures for procurement, product safety, patient relations, and business management and operations, which have been replicated by dispensaries around the nation. As a community leader, Goldsberry is active in the campaign to reform the California cannabis laws and to protect patient's rights. She co-founded and directed Americans for Safe Access (ASA), Medical Cannabis Safety Council (MCSC), and Cannabis Action Network (CAN). She is a former board member at California NORML and of the Marijuana Policy Project, and is a professor at Oaksterdam University, teaching dispensary operations and management. In 2017, Goldsberry published her first book, Idiot's Guide: Starting and Running a Marijuana Business (Penguin Random House). Goldsberry has been a staff writer at DOPE Magazine and High Times Medical Marijuana Magazine, was a featured blogger at ''Smell the Truth'' and ''Ladybud.'' She currently writes for Freedom Leaf and Cannabis Dispensary Magazine.

https://3fojcc1leuzj9dmih15q1u11-wpengine.netdna-ssl.com/wp-content/uploads/2017/11/headshot-e1510593713702.jpeg


Debby Goldsberry

About Cannabis Sativa, Inc.:

Cannabis Sativa, Inc. (''CBDS'') is engaged in the licensing of cannabis-related intellectual property, marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. CBDS licenses the ''hi'' and ''White Rabbit'' brands, holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, owns patent pending and trade secret formulas and processes, offers the hi benefits discount pharmacy card, and operates subsidiaries including: Wild Earth Naturals, Inc., (wildearthnaturals.com), iBudtender (www.ibudtender.com) and PrestoDoctor (www.prestodoctor.com). In addition, CBDS seeks strategic partners for the acquisition of operating companies, intellectual property and other assets which fit within the CBDS corporate vision.

https://s.yimg.com/bt/api/res/1.2/d97OShD5wAk8URauVLtOaQ--/YXBwaWQ9eW5ld3M7c209MTt3PTEyMjtoPTQxO2lsPXBsYW5l/https:/www.accesswire.com/users/newswire/images/482032/a01ea901-59b7-4150-a429-3c366f6773c7.png.cf.jpg

Forward-Looking Statements:

This press release contains ''forward-looking statements.'' Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company's success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contact Information:

Investor Relations
1646 West Pioneer Blvd. Suite 120
Mesquite, NV 89027
702-345-4074
http://www.cbds.com

SOURCE: Cannabis Sativa, Inc.